Open-label study of ademetionine for the treatment of intrahepatic cholestasis associated with alcoholic liver disease
{{output}}
Background: The effect of oral and/or parenteral ademetionine (500 mg intravenous [IV] and tablet formulation) on clinical symptoms and biochemical markers of intrahepatic cholestasis (IHC) was investigated in subjects with alcoh... ...
